Drugs / OLIMEL
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04012333 | Jun 2020 → Mar 2022 | myopathy, nutritional deficiency disease | RWTH Aachen University | Withdrawn | No outcome recorded |
| Phase 3 | NCT01206166 | Jun 2011 → Mar 2015 | acute respiratory failure | Clinical Evaluation Research Unit at Kingston General Hospital | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OLIMEL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04012333 ↗ |
| Modality | Other / unclassified | “OLIMEL(Amino Acids, Dextrose, Lipids, with / without Electrolytes)” NCT01206166 ↗ |
| Route | Intravenous | “parenteral nutrition (via an intravenous tube into the blood)” NCT01206166 ↗ |